Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EC HealthcareHKSE:02138 +1.12%56 FCF Margin % is 18.83% as of Mar. 2026, which is 35% above its 10-year median of 13.98. GuruFocus rates HKSE:02138 with a GF Score™ of 56/100 and a GF Value™ of HK$0.72 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 666 Healthcare Providers & Services companies, EC Healthcare ranks better than 88.74% on this metric.
FCF Margin % is calculated as Free Cash Flow divided by its Revenue. EC Healthcare's Free Cash Flow for the
six
months ended in Mar. 2026 was HK$346 Mil. EC Healthcare's Revenue for the
six
months ended in Mar. 2026 was HK$1,840 Mil. Therefore, EC Healthcare's FCF Margin % for the quarter that ended in Mar. 2026 was 18.83%.
The historical rank and industry rank for EC Healthcare's FCF Margin % or its related term are showing as below:
HKSE:02138'
s FCF Margin % Range Over the Past 10 Years
Min: -2.65 Med: 13.98 Max: 26
Current: 16.09
During the past 12 years, the highest FCF Margin % of EC Healthcare was 26.00%. The lowest was -2.65%. And the median was 13.98%.
HKSE:02138's FCF Margin % is ranked better than 88.74% of 666
companies
in the Healthcare Providers & Services industry
Industry Median: 3.025
vs HKSE:02138: 16.09
The historical data trend for EC Healthcare's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:02138 vs HCA, THC, DVA: FCF Margin % Comparison
For the Medical Care Facilities subindustry, EC Healthcare's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
EC Healthcare FCF Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, EC Healthcare's FCF Margin % distribution charts can be found below:
* The bar in red indicates where EC Healthcare's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EC Healthcare (HKSE:02138) has a FCF Margin % of 18.83% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on EC Healthcare and its competitors. This is 35% above median its historical median of 13.98. According to the industry distribution chart, EC Healthcare ranks #75 out of 666 companies in the Healthcare Providers & Services industry, placing it in the top 11.3%.
Is EC Healthcare's FCF Margin % too high?
EC Healthcare's current FCF Margin % of 18.83% is 35% above median its 10-year median of 13.98. The Healthcare Providers & Services industry median FCF Margin % is 3.03. EC Healthcare's value of 18.83% is 522.5% above this industry median. Based on the distribution chart, EC Healthcare ranks #75 out of 666 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, EC Healthcare has a GF Score™ of 56/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does EC Healthcare's FCF Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, EC Healthcare ranks #75 out of 666 companies for FCF Margin %. This places EC Healthcare in the top 11% of its industry — outperforming the majority of peers. The industry median FCF Margin % is 3.03. EC Healthcare's value of 18.83% is 522.5% above this benchmark. While the company's 10-year median is 13.98 vs. the industry median of 3.03, EC Healthcare has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Healthcare Providers & Services company?
The median FCF Margin % among Healthcare Providers & Services companies is 3.03, based on 666 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. EC Healthcare's current FCF Margin % of 18.83% is 522.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on EC Healthcare and its competitors. For the Healthcare Providers & Services industry, the median FCF Margin % is 3.03 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. EC Healthcare's current FCF Margin % is 18.83%, which is 35% above median its own 10-year median of 13.98. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is EC Healthcare stock overvalued right now?
Based on GuruFocus' analysis, EC Healthcare (HKSE:02138) is currently considered Possible Value Trap. The stock's GF Value™ is HK$0.72, compared to a current price of HK$0.45 — trading 37.5% below its estimated fair value. The current FCF Margin % is 18.83%, which is 35% above median its 10-year median of 13.98 and 522.5% above the Healthcare Providers & Services industry median of 3.03. EC Healthcare's overall GF Score™ is 56/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For EC Healthcare (HKSE:02138), the current FCF Margin % is 18.83% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is EC Healthcare (HKSE:02138) Overvalued in 2026?
Based on GuruFocus' analysis, EC Healthcare stock appears to be undervalued.
The current stock price of HK$0.45 is trading 37.5% below its estimated GF Value™ of HK$0.72.
GuruFocus considers EC Healthcare to be Possible Value Trap.
Key valuation signals for HKSE:02138:
FCF Margin %: 18.83% (35% above median its 10-year median of 13.98)
GF Value™: HK$0.72 vs. price of HK$0.45 (37.5% below fair value)
Industry Position: 522.5% above the Healthcare Providers & Services median (#75 of 666)
No single metric tells the full story. See the HKSE:02138 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
EC Healthcare is a Hong Kong-based non-hospital medical service provider. The principal activities of the group include the provision of medical services; aesthetic medical services, comprising medical aesthetics and dental services; beauty and wellness services, comprising traditional beauty, haircare, and ancillary wellness services; and the sale of skincare, healthcare, and beauty products. The group caters to its services through the operating segments of Medical, which is the key revenue generator segment and Aesthetic medical, beauty and wellness, Veterinary, and others. Geographically, the group has a business presence in Hong Kong, Macau, Mainland China, and Taiwan. It generates the majority of its revenue from Hong Kong.
56GF Score
Get the complete analysis for HKSE:02138
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02138 has been successfully added to your 
